Goldman Sachs’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $89.8M | Buy |
|
|||||
|
2025
Q2 | $42.1M | Sell |
|
|||||
|
2025
Q1 | $54.8M | Buy |
|
|||||
|
2024
Q4 | $56.7M | Buy |
|
|||||
|
2024
Q3 | $62.6M | Buy |
|
|||||
|
2024
Q2 | $61.7M | Buy |
|
|||||
|
2024
Q1 | $48.5M | Sell |
|
|||||
|
2023
Q4 | $68.1M | Buy |
|
|||||
|
2023
Q3 | $20.9M | Sell |
|
|||||
|
2023
Q2 | $36.1M | Buy |
|
|||||
|
2023
Q1 | $37.8M | Buy |
|
|||||
|
2022
Q4 | $41.7M | Buy |
|
|||||
|
2022
Q3 | $32.9M | Buy |
|
|||||
|
2022
Q2 | $18.5M | Sell |
|
|||||
|
2022
Q1 | $24.3M | Buy |
|
|||||
|
2021
Q4 | $25.5M | Sell |
|
|||||
|
2021
Q3 | $35.2M | Buy |
|
|||||
|
2021
Q2 | $11.1M | Sell |
|
|||||
|
2021
Q1 | $18.7M | Sell |
|
|||||
|
2020
Q4 | $17.1M | Sell |
|
|||||
|
2020
Q3 | $19.5M | Buy |
|
|||||
|
2020
Q2 | $19.2M | Buy |
|
|||||
|
2020
Q1 | $5.69M | Buy |
|
|||||
|
2019
Q4 | $3.47M | Buy |
|
|||||
|
2019
Q3 | $1.57M | Buy |
|
|||||
|
2019
Q2 | $1.16M | Sell |
|
|||||
|
2019
Q1 | $1.92M | Buy |
|
|||||
|
2018
Q4 | $1.07M | Buy |
|
|||||
|
2018
Q3 | $1.56M | Sell |
|
|||||
|
2018
Q2 | $2.48M | Sell |
|
|||||
|
2018
Q1 | $2.55M | Sell |
|
|||||
|
2017
Q4 | $3.4M | Buy |
|
|||||
|
2017
Q3 | $5M | Buy |
|
|||||
|
2017
Q2 | $3.46M | Buy |
|
|||||
|
2017
Q1 | $661K | Sell |
|
|||||
|
2016
Q4 | $869K | Sell |
|
|||||
|
2016
Q3 | $1.22M | Buy |
|
|||||
|
2016
Q2 | $976K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $372K | Buy |
|
|||||
|
2015
Q3 | $108K | Buy |
|
|||||
|
2015
Q2 | $47K | Buy |
|
|||||
|
2015
Q1 | $29K | Sell |
|
|||||
|
2014
Q4 | $630K | Buy |
|
|||||
|
2014
Q3 | $273K | Buy |
|
|||||
|
2014
Q2 | $72K | Sell |
|
|||||
|
2014
Q1 | $435K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $80K | Buy |
|